Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Scheiner

Showing results (31-40 of 203) with videos related to

Pageof 21
Sort By:
Journal of Hepatocellular Carcinoma|December 8, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Lorenz Balcar, Bernhard Scheiner, et al.
Cancers|December 17, 2024
The Influence of Sex and Age on Survival in Patients with Hepatocellular CarcinomaIuliana Pompilia Radu, Bernhard Scheiner, Jonas Schropp, et al.
Cancers|April 12, 2022
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary CentersVera Himmelsbach, Matthias Pinter, Bernhard Scheiner, et al.
Scientific Reports|August 14, 2019
Guideline-conform statin use reduces overall mortality in patients with compensated liver diseaseLukas W Unger, Bernadette Forstner, Stephan Schneglberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2017
Transferrin as a predictor of survival in cirrhosisAndré Viveiros, Armin Finkenstedt, Benedikt Schaefer, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Cancers|October 17, 2020
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Bernhard Scheiner, Dabin Park, et al.
Digestive Diseases and Sciences|December 26, 2019
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on MortalityLukas W Unger, Bernadette Forstner, Moritz Muckenhuber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2019
Prevalence of and risk factors for anaemia in patients with advanced chronic liver diseaseBernhard Scheiner, Georg Semmler, Florian Maurer, et al.
Pageof 21

Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
Journal of Hepatocellular Carcinoma|December 8, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Lorenz Balcar, Bernhard Scheiner, et al.
Cancers|December 17, 2024
The Influence of Sex and Age on Survival in Patients with Hepatocellular CarcinomaIuliana Pompilia Radu, Bernhard Scheiner, Jonas Schropp, et al.
Cancers|April 12, 2022
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary CentersVera Himmelsbach, Matthias Pinter, Bernhard Scheiner, et al.
Scientific Reports|August 14, 2019
Guideline-conform statin use reduces overall mortality in patients with compensated liver diseaseLukas W Unger, Bernadette Forstner, Stephan Schneglberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2017
Transferrin as a predictor of survival in cirrhosisAndré Viveiros, Armin Finkenstedt, Benedikt Schaefer, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Cancers|October 17, 2020
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Bernhard Scheiner, Dabin Park, et al.
Digestive Diseases and Sciences|December 26, 2019
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on MortalityLukas W Unger, Bernadette Forstner, Moritz Muckenhuber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2019
Prevalence of and risk factors for anaemia in patients with advanced chronic liver diseaseBernhard Scheiner, Georg Semmler, Florian Maurer, et al.
Pageof 21